Blog Archive

Search This Blog

Monday, July 31, 2017

Myoclonic dystonia (DYT11) responsive to insulin therapy: A case report

A 44-year-old man has been longitudinally followed for myoclonic dystonia (DYT11) due to a previously described heterozygous loss-of-function mutation involving a conserved residue in the epsilon-sarcoglycan gene (SGCE, NM_003919.2:c.1114C>T, p.Arg372Ter).1



from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2weX1bv

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...